Overview
- 4 inspections across 4 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-06-20.
At a glance
Inspections
4
Sites
4
Observations
4
Career since
Nov 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Flamma USA LLC | 20 Jun 2025 | Human Drugs | On file |
| Alcami Carolinas Corporation | 28 Mar 2025 | Human Drugs | View 483 → |
| CELLTRION Inc | 14 Jan 2025 | Human Drugs | |
| Nang Kuang Pharmaceutical Co. Ltd. | 7 Nov 2024 | Human Drugs | On file |
Sites inspected
Flamma USA LLCMalvern, United States1 insp.
Alcami Carolinas CorporationMorrisville, United States1 insp.
CELLTRION IncYeonsu District, Korea (the Republic of)1 insp.
Nang Kuang Pharmaceutical Co. Ltd.Tainan City, Taiwan1 insp.
Co-investigators
Investigators who share inspections with this person.
Prabuddha Sengupta1 shared
Ju Du1 shared
Hamet M Toure1 shared
Kevin P Regan1 shared
Jennifer L Huntington1 shared
Mia J Chang1 shared
Liqun Zhao1 shared
Thuy T Nguyen1 shared
Full investigator report
Get the verbatim findings behind Karthik M Krishnan's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site